These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 29321042)

  • 1. Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?
    Wahadat MJ; Bodewes ILA; Maria NI; van Helden-Meeuwsen CG; van Dijk-Hummelman A; Steenwijk EC; Kamphuis S; Versnel MA
    Arthritis Res Ther; 2018 Jan; 20(1):4. PubMed ID: 29321042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
    Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
    Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren's syndrome.
    Huijser E; Bodewes ILA; Lourens MS; van Helden-Meeuwsen CG; van den Bosch TPP; Grashof DGB; van de Werken HJG; Lopes AP; van Roon JAG; van Daele PLA; Brkic Z; Dik WA; Versnel MA
    Rheumatology (Oxford); 2022 Aug; 61(8):3491-3496. PubMed ID: 35022662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.
    Li Y; Lee PY; Kellner ES; Paulus M; Switanek J; Xu Y; Zhuang H; Sobel ES; Segal MS; Satoh M; Reeves WH
    Arthritis Res Ther; 2010; 12(3):R90. PubMed ID: 20478071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?
    Kyogoku C; Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Häupl T; Hiepe F; Alexander T; Radbruch A; Grützkau A
    PLoS One; 2013; 8(12):e83776. PubMed ID: 24391825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation of IFI44L as a potential blood biomarker for childhood-onset systemic lupus erythematosus.
    Wang J; Dang X; Wu X; Xiang Z; Li Y; Fu Y; Shen T
    Pediatr Res; 2024 Jul; 96(2):494-501. PubMed ID: 38514858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RIG-I-like receptors and autoimmune diseases.
    Kato H; Fujita T
    Curr Opin Immunol; 2015 Dec; 37():40-5. PubMed ID: 26530735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of an anti-RNA autoantibody in a mouse model of SLE increases neutrophil and monocyte numbers as well as IFN-I expression.
    Han JH; Umiker BR; Kazimirova AA; Fray M; Korgaonkar P; Selsing E; Imanishi-Kari T
    Eur J Immunol; 2014 Jan; 44(1):215-26. PubMed ID: 24105635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus.
    Shen M; Duan C; Xie C; Wang H; Li Z; Li B; Wang T
    Front Immunol; 2022; 13():962393. PubMed ID: 35967341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cluster of highly expressed interferon-stimulated genes associate more with African ancestry than disease activity in patients with systemic lupus erythematosus. A systematic review of cross-sectional studies.
    Siddiqi KZ; Wilhelm TR; Ulff-Møller CJ; Jacobsen S
    Transl Res; 2021 Dec; 238():63-75. PubMed ID: 34343626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferon-inducible genes lymphocyte antigen 6 complex E and tetratricopeptide repeats 1 are correlated with clinical features of patients with systemic lupus erythematosus].
    Tang JP; Gu YY; Shen N; Ye S; Qian J; Hua J; Chen XG; Chen SL; Bao CD; Wang Y; Zhang W
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1157-60. PubMed ID: 15387975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
    Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
    Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of miRNA associated with a disease-specific signature and secreted via extracellular vesicles of systemic lupus erythematosus patients suppresses target organ inflammation in a humanized mouse model.
    Young NA; Schwarz E; Zeno BM; Bruckner S; Mesa RA; Jablonski K; Wu LC; Roberson EDO; Jarjour WN
    Front Immunol; 2023; 14():1090177. PubMed ID: 38939646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population.
    García-Ortiz H; Velázquez-Cruz R; Espinosa-Rosales F; Jiménez-Morales S; Baca V; Orozco L
    Ann Rheum Dis; 2010 Oct; 69(10):1861-5. PubMed ID: 20525845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA downregulation in plasmacytoid dendritic cells in interferon-positive systemic lupus erythematosus and antiphospholipid syndrome.
    van den Hoogen LL; Rossato M; Lopes AP; Pandit A; Bekker CPJ; Fritsch-Stork RDE; van Roon JAG; Radstake TRDJ
    Rheumatology (Oxford); 2018 Sep; 57(9):1669-1674. PubMed ID: 29873766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.